FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

David Gold

Research Profile

Chemicals & Drugs

Disorders

Living Beings

Procedures

Concepts & Ideas

Tissue Distribution

Anatomy

Tumor Cell Line

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
David V Gold; Jochen Gaedcke; B Michael Ghadimi; Michael Goggins; Ralph Hruban; Mengling Liu; Guy Newsome; David M Goldenberg
PAM4 enzyme immunoassay alone and in combination with CA 19-9 for the detection of pancreatic adenocarcinoma.
David M Goldenberg; Chien-Hsing Chang; David V Gold; Donglin Liu; Meiyu Loo; Elaine S Jaffe
Horizontal transmission of malignancy: in-vivo fusion of human lymphomas with hamster stroma produces tumors retaining human genes and lymphoid pathology.
Xiaochuan Chen; David V Gold; Thomas M Cardillo; Chien-Hsing Chang; Rhona Stein; David M Goldenberg
Prevention of acute graft-versus-host disease in a xenogeneic SCID mouse model by the humanized anti-CD74 antagonistic antibody milatuzumab.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of David Gold (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2013: David V Gold; Jochen Gaedcke; B Michael Ghadimi; Michael Goggins; Ralph Hruban; Mengling Liu; Guy Newsome; David M Goldenberg
PAM4 enzyme immunoassay alone and in combination with CA 19-9 for the detection of pancreatic adenocarcinoma.
Cancer 2013;119(3):522-8.
2013: David M Goldenberg; Chien-Hsing Chang; David V Gold; Donglin Liu; Meiyu Loo; Elaine S Jaffe
Horizontal transmission of malignancy: in-vivo fusion of human lymphomas with hamster stroma produces tumors retaining human genes and lymphoid pathology.
PloS one 2013;8(2):e55324.
2013: Xiaochuan Chen; David V Gold; Thomas M Cardillo; Chien-Hsing Chang; Rhona Stein; David M Goldenberg
Prevention of acute graft-versus-host disease in a xenogeneic SCID mouse model by the humanized anti-CD74 antagonistic antibody milatuzumab.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(1):28-39.
2012: David M Goldenberg; Kerstin M Heselmeyer-Haddad; Meiyu Loo; Thomas Ried; David Zagzag; Lissa Y Berroa Garcia; Chien-Hsing Chang; David V Gold
Horizontal transmission and retention of malignancy, as well as functional human genes, after spontaneous fusion of human glioblastoma and hamster host cells in vivo.
International journal of cancer. Journal international du cancer 2012;131(1):49-58.
2010: David V Gold; Rhona Stein; Jack Burton; David M Goldenberg
Enhanced expression of CD74 in gastrointestinal cancers and benign tissues.
International journal of clinical and experimental pathology 2010;4(1):1-12.
2009: Habibe Karacay; Robert M Sharkey; David V Gold; Dan R Ragland; William J McBride; Edmund A Rossi; Chien-Hsing Chang; David M Goldenberg
Pretargeted radioimmunotherapy of pancreatic cancer xenografts: TF10-90Y-IMP-288 alone and combined with gemcitabine.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(12):2008-16.
2009: David E Modrak; Evelyn Leon; David M Goldenberg; David V Gold
Ceramide regulates gemcitabine-induced senescence and apoptosis in human pancreatic cancer cell lines.
Molecular cancer research : MCR 2009;7(6):890-6.
2008: David V Gold; David M Goldenberg; Habibe Karacay; Edmund A Rossi; Chien-Hsing Chang; Thomas M Cardillo; William J McBride; Robert M Sharkey
A novel bispecific, trivalent antibody construct for targeting pancreatic carcinoma.
Cancer research 2008;68(12):4819-26.
2007: David V Gold; Zarir Karanjawala; David E Modrak; David M Goldenberg; Ralph Hruban
PAM4-reactive MUC1 is a biomarker for early pancreatic adenocarcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(24):7380-7.
2006: David E Modrak; David V Gold; David M Goldenberg
Sphingolipid targets in cancer therapy.
Molecular cancer therapeutics 2006;5(2):200-8.
2006: David V Gold; David E Modrak; Zhiliang Ying; Thomas M Cardillo; Robert M Sharkey; David M Goldenberg
New MUC1 serum immunoassay differentiates pancreatic cancer from pancreatitis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(2):252-8.
2005: David E Modrak; Habibe Karacay; Thomas M Cardillo; Guy Newsome; David M Goldenberg; David V Gold
Identification of a Mu-9 (anti-colon-specific antigen-p)-reactive peptide having homology to CA125 (MUC16).
International journal of oncology 2005;26(6):1591-6.
2004: David E Modrak; Thomas M Cardillo; Guy A Newsome; David M Goldenberg; David V Gold
Synergistic interaction between sphingomyelin and gemcitabine potentiates ceramide-mediated apoptosis in pancreatic cancer.
Cancer research 2004;64(22):8405-10.
2004: Jack D Burton; Scott Ely; Praveen K Reddy; Rhona Stein; David V Gold; Thomas M Cardillo; David M Goldenberg
CD74 is expressed by multiple myeloma and is a promising target for therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(19):6606-11.
2004: Thomas M Cardillo; Habibe Karacay; David M Goldenberg; Dion Yeldell; Chien-Hsing Chang; David E Modrak; Robert M Sharkey; David V Gold
Improved targeting of pancreatic cancer: experimental studies of a new bispecific antibody, pretargeting enhancement system for immunoscintigraphy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(10):3552-61.
2004: David V Gold; David E Modrak; Keith Schutsky; Thomas M Cardillo
Combined 90Yttrium-DOTA-labeled PAM4 antibody radioimmunotherapy and gemcitabine radiosensitization for the treatment of a human pancreatic cancer xenograft.
International journal of cancer. Journal international du cancer 2004;109(4):618-26.
2003: David V Gold; Keith Schutsky; David E Modrak; Thomas M Cardillo
Low-dose radioimmunotherapy ((90)Y-PAM4) combined with gemcitabine for the treatment of experimental pancreatic cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 2):3929S-37S.
2003: P K Reddy; David V Gold; Thomas M Cardillo; David M Goldenberg; H Li; Jack D Burton
Interferon-gamma upregulates MUC1 expression in haematopoietic and epithelial cancer cell lines, an effect associated with MUC1 mRNA induction.
European journal of cancer (Oxford, England : 1990) 2003;39(3):397-404.
2003: David E Modrak; David V Gold; David M Goldenberg; Rosalyn D Blumenthal
Colonic tumor CEA, CSAp and MUC-1 expression following radioimmunotherapy or chemotherapy.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2003;24(1):32-9.
2002: Thomas M Cardillo; Rosalyn Blumenthal; Zhiliang Ying; David V Gold
Combined gemcitabine and radioimmunotherapy for the treatment of pancreatic cancer.
International journal of cancer. Journal international du cancer 2002;97(3):386-92.
2001: Thomas M Cardillo; Zhiliang Ying; David V Gold
Therapeutic advantage of (90)yttrium- versus (131)iodine-labeled PAM4 antibody in experimental pancreatic cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(10):3186-92.
2001: David V Gold; Thomas M Cardillo; David M Goldenberg; Robert M Sharkey
Localization of pancreatic cancer with radiolabeled monoclonal antibody PAM4.
Critical reviews in oncology/hematology 2001;39(1-2):147-54.
2001: David V Gold; Thomas M Cardillo
Monoclonal antibody G47 engineered to be reactive with colorectal tumor mucin.
Hybridoma and hybridomics 2001;20(5-6):343-50.
1999: Jack Burton; D Mishina; Thomas M Cardillo; K Lew; A Rubin; David M Goldenberg; David V Gold
Epithelial mucin-1 (MUC1) expression and MA5 anti-MUC1 monoclonal antibody targeting in multiple myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3065s-3072s.
1997: David V Gold; Thomas M Cardillo; Y Vardi; R Blumenthal
Radioimmunotherapy of experimental pancreatic cancer with 131I-labeled monoclonal antibody PAM4.
International journal of cancer. Journal international du cancer 1997;71(4):660-7.
1995: David V Gold; R Alisauskas; Robert M Sharkey
Targeting of xenografted pancreatic cancer with a new monoclonal antibody, PAM4.
Cancer research 1995;55(5):1105-10.
1994: David V Gold; K Lew; R Maliniak; M Hernandez; Thomas M Cardillo
Characterization of monoclonal antibody PAM4 reactive with a pancreatic cancer mucin.
International journal of cancer. Journal international du cancer 1994;57(2):204-10.
1990: Robert M Sharkey; David V Gold; R Aninipot; R Vagg; C Ballance; E S Newman; F Ostella; Hans J Hansen; David M Goldenberg
Comparison of tumor targeting in nude mice by murine monoclonal antibodies directed against different human colorectal cancer antigens.
Cancer research 1990;50(3 Suppl):828s-834s.
1989: David V Gold; G Ishizaki; P Keller; K Lew
Generation of a monoclonal antibody (G9) reactive with an organ-specific, tumor-associated epitope of human colon carcinoma.
Cancer research 1989;49(22):6412-8.
1989: David V Gold; D Shochat
Studies on the structure of the organ-specific determinant of human colonic mucin.
Molecular immunology 1989;26(8):769-77.
1988: David V Gold; M J Mattes
Monoclonal antibody B72.3 reacts with a core region structure of O-linked carbohydrates.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1988;9(2-3):137-44.
1986: David V Gold; G Ishizaki; D Shochat
Organ specific antigens of the human gastrointestinal tract.
Molecular immunology 1986;23(10):1031-7.
1983: E N Spremulli; C Scott; D E Campbell; N P Libbey; D Shochat; David V Gold; D L Dexter
Characterization of two metastatic subpopulations originating from a single human colon carcinoma.
Cancer research 1983;43(8):3828-35.
1983: David V Gold; D Shochat; F J Primus; D L Dexter; P Calabresi; David M Goldenberg
Differential expression of tumor-associated antigens in human colon carcinomas xenografted into nude mice.
Journal of the National Cancer Institute 1983;71(1):117-24.
1982: D Lee; D Shochat; David V Gold
alpha 1-Proteinase inhibitor production by human adenocarcinomas xenotransplanted into nude mice.
Journal of the National Cancer Institute 1982;69(2):381-5.
1981: David V Gold; D Shochat; F Miller
Protease digestion of colonic mucin. Evidence for the existence of two immunochemically distinct mucins.
The Journal of biological chemistry 1981;256(12):6354-8.
1981: D Shochat; R L Archey; K D Pant; H L Dahlman; David V Gold; David M Goldenberg
Characterization of colon-specific antigen-p and isolation of immunologically active tryptic peptides.
Journal of immunology (Baltimore, Md. : 1950) 1981;126(6):2284-9.
1980: David V Gold; D Shochat
A rapid colorimetric assay for the estimation of microgram quantities of DNA.
Analytical biochemistry 1980;105(1):121-5.
1980: J C Hager; David V Gold; J A Barbosa; Z Fligiel; F Miller; D L Dexter
N,N-dimethylformamide-induced modulation of organ- and tumor-associated markers in cultured human colon carcinoma cells.
Journal of the National Cancer Institute 1980;64(3):439-46.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.